NeuroPace NPCE
NASDAQ NPCE
$12.70 -0.45 (-3.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

NeuroPace (NPCE) Gains from Sales and Divestitures (2025)

Updated

NeuroPace's Gains from Sales and Divestitures was -$12,000 in Q4 2025.

Analysis

NeuroPace (NPCE) Gains from Sales and Divestitures (2025) Analysis & Trends

For FY2025, Gains from Sales and Divestitures at NeuroPace came in at -$14,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 NeuroPace 435.39 Mn 208.64 Mn 18.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -12,000.00
Mar 31, 2025 -2,000.00
API Access

NeuroPace Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NPCE&period=max&api_key=YOUR_API_KEY